FI950866A - Export of macromolecules to the cell nucleus with the aid of a translocation signal - Google Patents

Export of macromolecules to the cell nucleus with the aid of a translocation signal Download PDF

Info

Publication number
FI950866A
FI950866A FI950866A FI950866A FI950866A FI 950866 A FI950866 A FI 950866A FI 950866 A FI950866 A FI 950866A FI 950866 A FI950866 A FI 950866A FI 950866 A FI950866 A FI 950866A
Authority
FI
Finland
Prior art keywords
macromolecules
export
aid
cell nucleus
translocation signal
Prior art date
Application number
FI950866A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI950866A0 (en
Inventor
Thomas R Barnett
Rathindra C Das
Original Assignee
Miles Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miles Inc filed Critical Miles Inc
Publication of FI950866A0 publication Critical patent/FI950866A0/en
Publication of FI950866A publication Critical patent/FI950866A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/6415—Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Formation Of Insulating Films (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FI950866A 1992-08-25 1995-02-24 Export of macromolecules to the cell nucleus with the aid of a translocation signal FI950866A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93507492A 1992-08-25 1992-08-25
PCT/US1993/007945 WO1994004696A1 (en) 1992-08-25 1993-08-24 Translocation signal facilitated nuclear delivery of macromolecules

Publications (2)

Publication Number Publication Date
FI950866A0 FI950866A0 (en) 1995-02-24
FI950866A true FI950866A (en) 1995-04-24

Family

ID=25466554

Family Applications (1)

Application Number Title Priority Date Filing Date
FI950866A FI950866A (en) 1992-08-25 1995-02-24 Export of macromolecules to the cell nucleus with the aid of a translocation signal

Country Status (10)

Country Link
EP (1) EP0658210A1 (en)
JP (1) JPH08504565A (en)
KR (1) KR950703650A (en)
AU (1) AU674026B2 (en)
CA (1) CA2143308A1 (en)
FI (1) FI950866A (en)
IL (1) IL106760A (en)
NZ (1) NZ255870A (en)
WO (1) WO1994004696A1 (en)
ZA (1) ZA936189B (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674977A (en) * 1993-02-05 1997-10-07 The Ontario Cancer Institute Branched synthetic peptide conjugate
EP0693939A1 (en) * 1993-04-14 1996-01-31 Roche Diagnostics GmbH Nucleic acid tranfer peptides and their use for injecting nucleic acids into eucaryotic cells
EP0745134A1 (en) 1994-02-22 1996-12-04 Danafarber Cancer Institute Nucleic acid delivery system, method of synthesis and uses thereof
US6037329A (en) * 1994-03-15 2000-03-14 Selective Genetics, Inc. Compositions containing nucleic acids and ligands for therapeutic treatment
EP0753069A1 (en) * 1994-04-15 1997-01-15 Targeted Genetics Corporation Gene delivery fusion proteins
US6468981B1 (en) * 1994-07-29 2002-10-22 Emory University Compositions and methods for targeting pharmaceutically active materials to cells containing androgen receptors
WO1996013599A1 (en) * 1994-11-01 1996-05-09 Winfried Wels Nucleic acid transfer system
US6051429A (en) * 1995-06-07 2000-04-18 Life Technologies, Inc. Peptide-enhanced cationic lipid transfections
CA2251691A1 (en) * 1996-03-26 1997-10-02 Razvan T. Radulescu Peptides with antiproliferative properties
US5962415A (en) * 1996-09-20 1999-10-05 Bristol-Myers Squibb Co. Compositions comprising a peptide inhibitor of nuclear protein translocation and an immunosuppressant and methods of use thereof
US5877282A (en) * 1996-09-20 1999-03-02 Bristol-Myers Squibb Company Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof
DE19649645A1 (en) * 1996-11-29 1998-06-04 Hoechst Ag Multiple functional ligand system for target cell-specific transfer of nucleotide sequences
US6086900A (en) * 1997-03-26 2000-07-11 Board Of Regents, The University Of Texas Systems Methods and compositions for using membrane-penetrating proteins to carry materials across cell membranes
GB9713122D0 (en) * 1997-06-20 1997-08-27 Chiron Spa Novel method of DNA transfer into cells
WO1999007723A1 (en) * 1997-08-07 1999-02-18 University Of Maryland, Baltimore Nucleic acid uptake and release vehicle
US7166745B1 (en) 1998-11-12 2007-01-23 Invitrogen Corporation Transfection reagents
AU2983100A (en) * 1999-02-06 2000-08-25 Aurx, Inc. Drug delivery vehicle
DE19910419A1 (en) * 1999-03-10 2000-09-21 Aventis Pharma Gmbh Target Cell-Specific Multivalent Proteins (MVP)
FR2793414B1 (en) * 1999-05-10 2003-05-23 Centre Nat Rech Scient NUCLEIC ACID-ANTIBODY CONJUGATE FOR DELIVERING FOREIGN NUCLEIC ACID TO CELLS
US6387684B1 (en) * 1999-09-13 2002-05-14 Academia Sinica Topoisomerase 1-mediated DNA delivery
US8128922B2 (en) 1999-10-20 2012-03-06 Johns Hopkins University Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
CA2388045C (en) * 1999-10-20 2014-02-11 Tzyy-Choou Wu Nucleic acid immunogenic compositions encoding hsp-antigen chimera
DE10019157A1 (en) * 2000-04-18 2001-11-15 Stefan Duebel Method for introducing ligands into living cells
ES2454640T3 (en) 2000-08-03 2014-04-11 Johns Hopkins University Molecular vaccine that carries a chaperone polypeptide from the endoplasmic reticulum to an antigen
US7198924B2 (en) 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
WO2002083166A1 (en) * 2001-04-10 2002-10-24 Santen Pharmaceutical Co., Ltd. Interferon-polymer complexes and medicinal use thereof
EP1947116B1 (en) * 2003-02-10 2017-06-21 2-BBB Medicines B.V. Differentially expressed nucleic acids in the blood-brain barrier under inflammatory conditions
WO2004098526A2 (en) 2003-05-05 2004-11-18 Johns Hopkins University Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
WO2005054438A2 (en) 2003-12-01 2005-06-16 Invitrogen Corporation Nucleic acid molecules containing recombination sites and methods of using the same
AU2005322960A1 (en) 2005-01-06 2006-07-13 The Johns Hopkins University RNA interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by DNA and transfected dendritic cell vaccines
US9085638B2 (en) 2007-03-07 2015-07-21 The Johns Hopkins University DNA vaccine enhancement with MHC class II activators
WO2010007593A1 (en) * 2008-07-18 2010-01-21 Chee Keong Choo Methods of long-term culture of eukaryotic cells and uses thereof
CN106572974B (en) 2014-07-15 2021-04-23 生命技术公司 Compositions and methods having lipid aggregates for efficient delivery of molecules to cells

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05505102A (en) * 1989-12-21 1993-08-05 ホワイトヘツド・インスチチユート・フオー・バイオメデイカル・リサーチ How to deliver molecules into eukaryotic cells
CA2092319A1 (en) * 1990-09-25 1992-03-26 George Y. Wu Prolonging expression of polynucleotides introduced into a cell
DE4139001A1 (en) * 1991-11-27 1993-06-03 Boehringer Mannheim Gmbh PROCESS FOR INJECTION OF NUCLEAR ACIDS IN CELLS
WO1993017102A1 (en) * 1992-02-19 1993-09-02 The Trustees Of The University Of Pennsylvania MODULATIONS OF CELLULAR FUNCTIONS WITH HnRNP PROTEINS
CA2131620A1 (en) * 1992-03-20 1993-09-30 Louis C. Smith A dna transporter system and method of use

Also Published As

Publication number Publication date
AU674026B2 (en) 1996-12-05
FI950866A0 (en) 1995-02-24
JPH08504565A (en) 1996-05-21
KR950703650A (en) 1995-09-20
ZA936189B (en) 1995-01-10
WO1994004696A1 (en) 1994-03-03
AU5088593A (en) 1994-03-15
NZ255870A (en) 1996-09-25
EP0658210A1 (en) 1995-06-21
CA2143308A1 (en) 1994-03-03
IL106760A0 (en) 1993-12-08
IL106760A (en) 1999-12-31

Similar Documents

Publication Publication Date Title
FI950866A (en) Export of macromolecules to the cell nucleus with the aid of a translocation signal
LV10314A (en) Macrocyclic coupling yield
MX164501B (en) PLASTIC CLOSURE WITH STRUCTURAL THREADED FORMATION
DK612586A (en) fUEL CELL
BR8804791A (en) TWIN COUNTER AXLES WITH FLOATING MAIN AXIS
NO850601L (en) DEVICE FOR IMPLEMENTING GEOPHYSICAL MEASUREMENTS IN A BILL
DK55389A (en) PRODUCTION COURSE
NO930056L (en) CENTRAL SYMMETRIC FUEL CELL BATTERY
PT83274A (en) RETRACTABLE MOLE NUCLEUS
BR8804922A (en) COUNTER
AU5862680A (en) Highway delineator post
ES547660A0 (en) IMPROVEMENTS IN THE DEVICES TO MANUFACTURE ZIPPER CLOSURES
BR8605962A (en) LANCACIDINE DERIVATIVES AND THEIR PRODUCTION
IT8621651A1 (en) Improvements made to electrostatic precipitation
DE69030220T2 (en) Signal compensator
ES547076A0 (en) IMPROVEMENTS IN THE DEVICES TO MANUFACTURE ZIPPER CLOSURES
DK161989A (en) ACRYLIC ACID DERIVATIVES
DK538689A (en) penicillanic acid derivatives
ATA11088A (en) METAL-ENCLOSED CONTROL CELL
ES547593A0 (en) IMPROVEMENTS IN THE DEVICES TO MANUFACTURE ZIPPER CLOSURES
FR2584264B1 (en) SPACER FOR OYSTER COLLECTORS
KR900000801U (en) Lane indicator
KR860013424U (en) Left toilet with alarm
SE9203523D0 (en) BACKGROUND FORCES FOR ENERGY PRODUCTION
SE8801114D0 (en) SECURITY ARRANGEMENTS BY A THORR

Legal Events

Date Code Title Description
HC Name/ company changed in application

Owner name: BAYER CORPORATION

FD Application lapsed